Seeking Alpha

Ilumina (ILMN) is down 3.7% after Leerink Swann downgrades the company to Market Perform, and...

Ilumina (ILMN) is down 3.7% after Leerink Swann downgrades the company to Market Perform, and lowers its valuation range to $53-$57. The firm thinks the growth of Ilumina's high-end HiSeq genetic sequencing systems is decelerating over the short-term, and think NIH budget cuts could also hurt the company.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs